Regavirumab

From Self-sufficiency
Revision as of 17:53, 14 July 2010 by Citation bot 1 (Talk) (Citations: [Pu173] added: first2, first3, first4, first5, first6, first7, first8. You can use this bot yourself! Report bugs here.)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Regavirumab
Monoclonal antibody
Type Whole antibody
Source Template:Infobox drug/mab source
Target cytomegalovirus glycoprotein B
Identifiers
CAS Number 153101-26-9
ATC code none
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Regavirumab is a human monoclonal antibody against infections with cytomegalovirus.[1]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />


  1. Arizono, H; Sugano, T; Kaida, S; Shibusawa, K; Karasawa, Y; Esumi, Y; Kondo, S; Kiyoki, M (1994). "Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys". Arzneimittel-Forschung. 44 (7): 909–13. PMID 7945531.